Has Saadia Raza, MD received payments from drug or device companies?

Yes. Drug and device makers reported $505 in general payments to Saadia Raza, MD across 4 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Saadia Raza, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Saadia Raza, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Saadia Raza, MD

Dermatology · O Fallon, MONPI 1285727461

Payments from drug & device makers

$505in general payments, 2019–2025

Across 4 payments — averaging $126.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Regeneron$135
Organogenesis Inc.$125
Janssen Scientific Affairs, LLC$124
E.r. Squibb & Sons, L.L.C.$121

What the payments were for

Food & beverage$505100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Regeneron	1	$135
Organogenesis Inc.	1	$125
Janssen Scientific Affairs, LLC	1	$124
E.r. Squibb & Sons, L.L.C.	1	$121

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$505 in reported general payments places this provider in the 15th percentile of 263 dermatology providers in Missouri.

See all dermatology providers in Missouri →

Medicare billing

Part B allowed, 2024

$750,901

Medicare patients

388

Services billed

2,313

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	311	$3,077
Cephalexin	71	$407
Gentamicin Sulfate	12	$326
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	35	$232
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	16	$132
Azithromycin	29	$102
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	18	$92

Paid to pharmacies, not to this prescriber.

Other dermatology in O Fallon

Robyn FanderclaiO Fallon$25K
Melody StoneSaint Joseph$4.3M
Milan AnadkatSaint Louis$2.4M
Brian KimSaint Louis$2.3M
Elaine SiegfriedSaint Louis$2.2M
Craig LeonardiSaint Louis$1.7M
David CleaverKirksville$789K
Amy MusiekSaint Louis$577K
Ann MartinSaint Louis$512K
Jonathan CleaverKirksville$483K

See the full list for Missouri →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →